Olokizumab Tender in Russia - 138255027

The FEDERAL STATE BUDGETARY RESEARCH INSTITUTION "RESEARCH INSTITUTE OF FUNDAMENTAL AND CLINICAL IMMUNOLOGY" has issued a Tender notice for the procurement of a Olokizumab in the Russia. This Tender notice was published on 21 Mar 2026 and is scheduled to close on 02 Apr 2026, with an estimated Tender value of 4290000.00. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 138255027, while the tender notice number is 0351100021926000189 and Registering on the platform.

Expired Tender

Procurement Summary

Country: Russia

Summary: Olokizumab

Deadline: 02 Apr 2026

Posting Date: 21 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 138255027

Document Ref. No.: 0351100021926000189

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: 4290000.00

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Olokizumab

Documents

 Tender Notice


Similar Tenders

GiZ Tenders India

Procurement Documents for Russia

Access a comprehensive library of standard procurement documents specific to Russia. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Russia

Explore Procurement Documents for Russia


Want To Bid in This Tender?

Get Local Agent Support in Russia and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?